News | November 18, 2014

Mevion and Philips Collaborate to Offer Treatment Planning Solutions for Proton Pencil Beam Scanning

Companies to develop Pinnacle³ proton planning for the Mevion S250 proton therapy system featuring Hyperscan

Mevion Medical Systems, Inc. and Philips Radiation Oncology Systems are collaborating to combine the treatment planning capability of Philips’ Pinnacle³ radiation therapy planning system with the Mevion S250 solution with Hyperscan, Mevion’s new pencil beam scanning technology that is capable of scanning a tumor in seconds.

Pinnacle³ currently supports the Mevion S250, the world’s smallest proton therapy platform. The new collaboration will focus on enabling the Pinnacle³ system to also support Hyperscan.

Hyperscan is an advanced form of pencil-beam scanning and is only available on the Mevion S250. Since Pinnacle³ is already being used by certain Mevion S250 users, it’s only fitting that we work together to develop planning for Hyperscan,” said Joe Jachinowski, the president and chief executive officer of Mevion Medical Systems.

“We’re really pleased to be collaborating with Mevion as it introduces Hyperscan,” said Sue Wallace, PhD, general manager of Philips Radiation Oncology Systems. “At Philips, treatment planning is a critical element of informed therapy guidance, and the integration of Philips imaging and planning with therapy delivery systems is essential.”

The first site to use Pinnacle³ with the Mevion S250 is the UF Health Cancer Center at Orlando Health. Omar Zeidan, Ph.D., the center’s chief of proton therapy physics, noted, “The collaboration between Philips and Mevion will give world-class cancer centers like ours the ability to offer patients all the benefits of HYPERSCAN combined with the accuracy and reliability of Pinnacle³.”  Zeidan added, “This will help lead to well-planned and well-executed proton therapy sessions that accurately target tumors.”

Hyperscan’s patented technology, paired with the direct and efficient proton beam generation of the Mevion S250 platform, allows tumor volumes to be quickly scanned in a matter of seconds. This speed makes Hyperscan’s treatment delivery much less sensitive to patient and tumor motion. 

The Mevion S250’s revolutionary compact design removes the obstacles of size, complexity and cost that exist with conventional proton therapy systems without compromising beam quality or patient care. It was first installed at Barnes Jewish Hospital in St. Louis. Five other Mevion S250 installations are currently in process.

HYPERSCAN has not been cleared by the USFDA for clinical use.

For more information:

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation
News | Proton Therapy | May 02, 2019
IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA proton therapy gantry treatment...
Pencil Beam Scanning Better Protects Children With Brain Tumors
News | Proton Therapy | May 01, 2019
A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil...
California Protons Cancer Therapy Center Begins Breast Cancer Study Enrollment
News | Proton Therapy | April 25, 2019
California Protons Cancer Therapy Center announced two major efforts representing significant steps forward in breast...
Philips Unveils IntelliSpace Radiation Oncology at ESTRO 2019
News | Oncology Information Management Systems (OIMS) | April 25, 2019
Philips announced IntelliSpace Radiation Oncology, an intelligent patient management solution to manage complexity,...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...